Filing Details
- Accession Number:
- 0001179110-14-017222
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-26 17:06:22
- Reporting Period:
- 2014-11-25
- Filing Date:
- 2014-11-26
- Accepted Time:
- 2014-11-26 17:06:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1587070 | Jaime Contreras | 100 Abbott Park Road Abbott Park IL 60064 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2014-11-25 | 33,900 | $26.70 | 64,036 | No | 4 | M | Direct | |
Common Shares Without Par Value | Acquisiton | 2014-11-25 | 17,700 | $26.02 | 81,736 | No | 4 | M | Direct | |
Common Shares Without Par Value | Disposition | 2014-11-25 | 1,100 | $44.06 | 80,636 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2014-11-25 | 300 | $44.06 | 80,336 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2014-11-25 | 11,374 | $44.07 | 68,962 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2014-11-25 | 35,607 | $44.07 | 33,355 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2014-11-25 | 200 | $44.07 | 33,155 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2014-11-25 | 300 | $44.07 | 32,855 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2014-11-25 | 1,064 | $44.08 | 31,791 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2014-11-25 | 255 | $44.09 | 31,536 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2014-11-25 | 1,400 | $44.09 | 30,136 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Disposition | 2014-11-25 | 33,900 | $0.00 | 33,900 | $26.70 |
Common Shares | Option (right to buy) | Disposition | 2014-11-25 | 17,700 | $0.00 | 17,700 | $26.02 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-02-15 | 2018-02-14 | No | 4 | M | Direct |
0 | 2012-02-20 | 2019-02-19 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Shares Without Par Value | 20 | Indirect | Profit Sharing Trust |
Common Shares Without Par Value | 63,903 | Indirect | Jaime Contreras Marvan 2006 Living Trust |
Common Shares Without Par Value | 2,046 | Indirect | By spouse |
Common Shares Without Par Value | 12,081 | Indirect | Living Trust (by spouse) |
Footnotes
- Balance in the Abbott Laboratories Stock Retirement Trust as of November 25, 2014.
- Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
- The reporting person disclaims beneficial ownership of all securities held by his spouse.
- Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.
- Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.